SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-220259
Filing Date
2013-05-15
Accepted
2013-05-14 21:09:15
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d507555d10q.htm 10-Q 366165
2 EX-31.1 d507555dex311.htm EX-31.1 5813
3 EX-31.2 d507555dex312.htm EX-31.2 5814
4 EX-32.1 d507555dex321.htm EX-32.1 4987
  Complete submission text file 0001193125-13-220259.txt   2468067

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT prta-20130331.xml EX-101.INS 305933
6 XBRL TAXONOMY EXTENSION SCHEMA prta-20130331.xsd EX-101.SCH 23692
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prta-20130331_cal.xml EX-101.CAL 37438
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prta-20130331_def.xml EX-101.DEF 76340
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE prta-20130331_lab.xml EX-101.LAB 195245
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prta-20130331_pre.xml EX-101.PRE 153403
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 353 1 709 4700
Prothena Corp plc (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35676 | Film No.: 13843513
SIC: 2834 Pharmaceutical Preparations